Comparative analysis of psychoemotional, clinical and social correlates of motivation for treatment in alcohol versus stimulant dependence

Gromyko D. I.

Nechaeva A. I.

Alekseeva Yu. V.

Roerich D. S.

Vuks A. Ya.

Krupitsky E. M.

Ilyuk R. D.

Dmitry I. Gromyko; e-mail: dmgrom@list.ru

The study had no sponsorship support.

The authors declare no conflict of interest.

20.03.2026

29.04.2026

Introduction. The presence of treatment motivation determines the likelihood of achieving positive outcomes in substance use treatment. An integrative study of the correlates of motivation for treatment in patients with alcohol and stimulant dependence may help identify common and specific biopsychosocial characteristics associated with the need for substance use treatment. Objective: To study and conduct a comparative analysis of the correlations between motivation for treatment and sociodemographic, clinical, and psychological characteristics in patients with alcohol dependence (AD) and stimulant dependence (SD). Materials and Methods. A cross-sectional study included 138 patients with alcohol dependence (F10.20; F10.21) and 102 patients with stimulant dependence (F15.20; F15.21). The study used data from the following sources: patients’ clinical charts, the «Stages of Change Readiness and Treatment Eagerness Scale» (SOCRATES), the Differential Emotions Scale (DES), the State-Trait Anxiety Inventory (STAI), the Hamilton Depression Rating Scale (HDRS), the State-Trait Anger Expression Inventory (STAXI), the «Type of Attitude Toward Illness» questionnaire (TOBOL), the Toronto Alexithymia Scale (TAS), and the Purpose-in-Life Test (PIL). Results. For both groups, common positive correlates of motivation for treatment were identified, including older age, later age of onset of withdrawal syndrome, number of previous treatment episodes, duration of remissions following treatment, the ratio of remission duration to illness duration, and the «Life Productivity» (PIL) score. A negative correlation between motivation for treatment and the severity of «Depression» (HDRS) was observed in both groups. In patients with SD, motivation for treatment was associated with a good relationship with the father, longer illness duration, and the explicit emotions of «Guilt» (DES) and «Interest» (DES). In patients with AD, treatment motivation was correlated with a positive attitude toward relatives, family demands to stop substance use, awareness that substance use interferes with work, and the «Life Process» (PIL) score. Additionally, in the AD group, treatment motivation negatively correlated with the severity of «Alexithymia» (TAS-26), «Trait Anxiety» (STAI), «Anger Proneness» (STAXI), and an anxious type of attitude toward illness (TOBOL). Comparative analysis indicates that in the SD group, motivation for treatment is more strongly associated with the duration of withdrawal syndrome and the emotion «Interest» (DES) than in patients with AD. In patients with AD, motivation for treatment is more strongly positively associated with the age of onset of withdrawal syndrome and the «Life Productivity» (PIL) score. The AD group shows a significantly stronger negative correlation between readiness for treatment and «Anger Proneness» (STAXI) compared to the SD group. Conclusion. The identified common and specific correlates of motivation in patients with AD and SD justify the need for a differentiated approach to treatment and rehabilitation interventions.

alcohol dependence, stimulant dependence, correlates, motivation for treatment, emotions, social and clinical factors

10.29234/2308-9113-2026-14-2-95-119

1. Eddie D., Vilsaint C.L., Hoffman L.A., Bergman B.G., Kelly J.F., Hoeppner B.B. From working on recovery to working in recovery: Employment status among a nationally representative U.S. sample of individuals who have resolved a significant alcohol or other drug problem. J Subst Abuse Treat. 2020; 113: 108000. doi: 10.1016/j.jsat.2020.108000.

2. Birkeland B., Weimand B., Ruud T., Maybery D., Vederhus J-K. Perceived family cohesion, social support, and quality of life in patients undergoing treatment for substance use disorders compared with patients with mental and physical disorders. Addict Sci Clin Pract. 2021; 16(1): 44. doi:10.1186/s13722-021-00252-8.

3. Siefried K.J., Acheson S.L., Lintzeris N., Ezard N. Pharmacological treatment of methamphetamine/amphetamine dependence: a systematic review meta-analysis. CNS Drugs 2020; 34(4): 337-365. doi: 10.1007/s40263-020-00711-x.

4. Eddie D., Greene M.C., White W.L., Kelly J.F. Medical burden of disease among individuals in recovery from alcohol and other drug problems in the United States: findings from the national recovery survey. J Addict Med. 2019; 13(5): 385-395. doi: 10.1097/ADM.0000000000000512.

5. Kirzhanova V.V., Grigorova N.I., Bobkov E.N., Kirzhanov V.N., Sidorjuk O.V. Dejatel'nost' narkologicheskoj sluzhby v Rossijskoj Federacii v 2021 godu: Analiticheskij obzor. [Activities of the Narcological Service in the Russian Federation in 2021: Analytical Review]. M.: FGBU «NMIC PN im. V.P. Serbskogo» Minzdrava Rossii, 2022. 202 p. (In Russ.)

6. Shimu S., Patil S.M., Dadzie E., Tesfaye T., Alag P., Więckiewicz G. Exploring health informatics in the battle against drug addiction: digital solutions for the rising concern. J Pers Med. 2024; 14(6): 556. doi: 10.3390/jpm14060556.

7. Armoon B., Grenier G., Cao Z., Huỳnh C., Fleury M.J. Frequencies of emergency department use and hospitalization comparing patients with different types of substance or polysubstance-related disorders. Subst Abuse Treat Prev Policy 2021; 18; 16 (1): 89. doi: 10.1186/s13011-021-00421-7.

8. Probst C., Manthey J., Martinez A., Rehm J. Alcohol use disorder severity and reported reasons not to seek treatment: a cross-sectional study in European primary care practices. Subst Abuse Treat Prev Policy. 2015; 10(1): 32. doi: 10.1186/s13011-015-0028-z.

9. Lappan S.N., Brown A.W., Hendricks P.S. Dropout rates of in-person psychosocial substance use disorder treatments: a systematic review and meta-analysis. Addiction 2020;115(2): 201-217. doi: 10.1111/add.14793.

10. Leite J.C.C., Luz M.F.D., Walz J.C., Filippin L.I., Saldanha R.P., Drachler M.L. Motivation and adherence to psychosocial treatment for alcohol and drug use-related problems. Health psychology. Estud. psicol. 2018; 35(4): 389-398. doi: 10.1590/1982-02752018000400006.

11. Day E., Manitsa I., Farley A., Kelly J.F. The UK National Recovery Survey: nationally representative survey of people overcoming a drug or alcohol problem. BJPsych Open 2024; 10(2): e67. doi: 10.1192/bjo.2023.654.

12. Klimanova S.G., Trusova A.V., Kiselev A.S., Berncev V.A., Gromyko D.I., Iljuk R.D., Krupickij E.M. Adaptacija russkojazychnoj versii oprosnika dlja ocenki gotovnosti k izmenenijam. [Adaptation of the Russian-language version of the questionnaire to assess readiness for change] (SOCRATES). Konsul'tativnaja psihologija i psihoterapija [Counseling psychology and psychotherapy]. 2018; 3 (101): 80-104. doi: 10.17759/cpp.2018260305. (In Russ.)

13. Eres'ko D.B., Isurina G.L., Kajdanovskaja E.V., Karvasarskij B.D., Karpova Je.B., Korepanova T.G., Krylova G.S., Tarhan A.U., Chehlatyj E.I., Shifrin V.B. Aleksitimija i metody ee opredelenija pri pogranichnyh i psihosomaticheskih rasstrojstvah: metodicheskoe posobie. [Alexithymia and methods of its determination in borderline and psychosomatic disorders: methodological manual]. Sankt-Petersburg: S.-Pb. NIPNI im. V.M. Behtereva, 2005. 25 p. (In Russ.)

14. Batarshev A.V. Bazovye psihologicheskie svojstva i samoopredelenie lichnosti. Prakticheskoe rukovodstvo po psihologicheskoj diagnostike. [Basic psychological properties and self-determination of personality. A Practical Guide to Psychological Diagnosis]. SPb.: Rech', 2005. 208 p. (In Russ.)

15. Hamilton M. A Rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 1960; (23): 56-62. doi: 10.1136/jnnp.23.1.56.

16. Leonova A.B., Kapica M.S. Metody sub#ektivnoj ocenki funkcional'nyh sostojanij cheloveka. Praktikum po inzhenernoj psihologii i jergonomike. Pod red. Ju.K. Strelkova [Methods for subjective assessment of human functional states. Workshop on engineering psychology and ergonomics. Ed. Yu.K. Strelkova]. M.: Akademija, 2003. p. 136-167. (In Russ.)

17. Solovjova S.L., Merkurjeva A.A., Kovaliova M.V. Rezul’taty issledovanija psihometricheskih svojstv russkojazychnoj versii metodiki Spilbergera (STAXI). [The researching results of the psychometric properties of the russian version Spilberger’’s methodic (STAXI)]. Sibirskij psihologicheskij zhurnal [Siberian journal of psychology] 2000; (3): 90-93. (In Russ.)

18. Vasserman L.I., Iovlev B.V., Karpova Je.B., Vuks A.Ja. Psihologicheskaja diagnostika otnoshenija k bolezni. [Psychological diagnosis of attitude to the disease]. St. Petersburg: SPb NIPNI im. V.M. Behtereva, 2005 (In Russ.)

19. Leont'ev D.A. Test smyslozhiznennyh orientacij. 2-e izd. [Meaningful life orientations test. Second ed.]. M.: Smysl, 2000. 18 p. (In Russ.)

20. Watkins K.E., Ober A., McCullough C., Setodji C., Lamp K., Lind M., Hunter S.B., Chan Osilla K. Predictors of treatment initiation for alcohol use disorders in primary care. Drug Alcohol Depend. 2018; 191: 56-62. doi: 10.1016/j.drugalcdep.2018.06.021.

21. Janssen A.G., Kennair L.E.O., Hagen R., Hjemdal O., Havnen A., Solem S. Positive and negative metacognitions about alcohol: Validity of the Norwegian PAMS and NAMS. Addict Behav. 2020; 108: 106466. doi: 10.1016/j.addbeh.2020.106466.

22. Beynon C.M., McMinn A.M., Marr A.J.E. Factors predicting drop out from, and retention in, specialist drug treatment services: a case control study in the North West of England. BMC Public Health 2008; 8(1): 149. doi: 10.1186/1471-2458-8-149.

23. Cucciare M.A., Ounpraseuth S.T., Curran G.M., Booth B.M. Predictors of mental health and substance use disorder treatment use over 3 years among rural adults using stimulants. Subst Abus. 2019; 40(3): 363-370. doi: 10.1080/08897077.2018.1547809.

24. Lee M.R., Sher K.J. «Maturing Out» of binge and problem drinking. Alcohol Res. 2018; 39: 31-42. doi: 10.35946/arcr.v39.1.06.

25. Ilyuk R.D., Erofeeva N.A., Gromyko D.I., Kiselev A.S., Krupitsky E.M. Social'no-psihologicheskie, klinicheskie i povedencheskie korreljaty kachestva zhizni opioidzavisimyh s VICh-negativnym i VICh-pozitivnym statusami. [Socio-psychological, clinical and behavioral correlates of the quality of life of opioid addicts with HIV-negative and HIV-positive statuses]. Voprosy narkologii [Narcology questions] 2019; 7 (178): 5-32. doi: 10.47877/0234-0623 (In Russ.)

26. Das P.R., Talukdar R.R., Kumar C.J. Exploring the interplay of abstinence self-efficacy, locus of control, and perceived social support in substance use disorder recovery. Curr Med Res Opin. 2024; 40(9): 1625-1635. doi: 10.1080/03007995.2024.2390046.

27. McCrady B.S., Flanagan J.C. The role of the family in alcohol use disorder recovery for adults. Alcohol Res. 2021; 41: 6. doi.org/10.35946/arcr.v41.1.06.

28. Härd S., Best D., Sondhi A., Lehman J., Riccardi R. The growth of recovery capital in clients of recovery residences in Florida, USA: a quantitative pilot study of changes in REC-CAP profile scores. Subst Abuse Treat Prev Policy 2022; 17(1): 58. doi: 10.1186/s13011-022-00488-w.

29. Cloud W., Granfield R. Conceptualizing recovery capital: expansion of a theoretical construct. Subst Use Misuse 2008; 43 (12-13): 1971-1986. doi: 10.1080/10826080802289762.

30. Goodyear K., Vasaturo-Kolodner T.R., Kenna G.A., Swift R.M., Leggio L., Haass-Koffler C.L. Alcohol-related changes in behaviors and characteristics from the baseline to the randomization session for treatment and non-treatment seeking participants with alcohol use disorder. Am J Drug Alcohol Abuse 2021; 47(6): 760-768. doi: 10.1080/00952990.2021.1961799.

31. Haass-Koffler C.L., Piacentino D., Li X., Long V.M., Lee M.R., Swift R.M., Kenna G.A., Leggio L. Differences in sociodemographic and alcohol related clinical characteristics between treatment seekers and nontreatment seekers and their role in predicting outcomes in the COMBINE study for alcohol use disorder. Alcoholism: Clinical and Experimental Research 2020; 44(10): 2097-108. doi: 10.1111/acer.14428.

32. Gromyko D.I., Nechaeva A.I., Alekseeva Y.V., Tikhomirov D.I., Kiselev A.S., Krupitsky E.M., Ilyuk R.D. Rol' social'no-demograficheskih, klinicheskih i psihoemocional'nyh harakteristik v formirovanii motivacii k izmeneniyu i lecheniyu u bol'nyh s alkogol'noj zavisimost'yu. [The role of sociodemographic, clinical, psychological, and emotional characteristics in the shaping of the motivation for change and readiness for treatment in patients with alcohol dependence]. Medicina 2024; 3: 11-24. doi:10.29234/2308-9113-2024-12-3-1-24.

33. Kelly J.F., Magill M., Stout R.L. How do people recover from alcohol dependence? A systematic review of the research on mechanisms of behavior change in Alcoholics Anonymous. Addiction Research & Theory 2009; 17: 236-259. doi: 10.1080/16066350902770458.

34. Kelly J.F., Bergman B., Hoeppner B.B., Vilsaint C.L., White W.L. Prevalence and pathways of recovery from drug and alcohol problems in the United States population: Implications for practice, research, and policy. Drug Alcohol Depend. 2017; 181: 162-169. doi: 10.1016/j.drugalcdep.2017.09.028.

35. Best D., Vanderplasschen W., Van de Mheen D., De Maeyer J., Colman C., Vander Laenen F., Irving J., Andersson C., Edwards M., Bellaert L., Martinelli T., Graham S., Hamer R., Nagelhout G.E. REC-PATH (recovery pathways): overview of a four-country study of pathways to recovery from problematic drug use. Alcohol Treat Q. 2018; 36(4): 517-529. doi: 10.1080/07347324.2018.1488550.

36. Cunningham J.A. Remissions from drug dependence: is treatment a prerequisite? Drug Alcohol Depend 2000; 59(3): 211-213. doi: 10.1016/s0376-8716(99)00123-4.

37. Witkiewitz K., Masyn K.E. Drinking trajectories following an initial lapse. Psychol Addict Behav. 2008; 22(2): 157-167. doi: 10.1037/0893-164X.22.2.157.

38. Scott C.K., Dennis M.L., Foss M.A. Utilizing recovery management checkups to shorten the cycle of relapse, treatment reentry, and recovery. Drug Alcohol Depend. 2005; 78(3): 325-338. doi: 10.1016/j.drugalcdep.2004.12.005.

39. Simpson D.D. A national 5 year follow up of treatment outcomes for cocaine dependence. Arch Gen Psychiatry 2002; 59(6): 538-544. doi:10.1001/archpsyc.59.6.538.

40. Kelly J.F., Greene M.C., Bergman B.G., White W.L., Hoeppner B.B. How many recovery attempts does it take to successfully resolve an alcohol or drug problem? Estimates and correlates from a national study of recovering U.S. adults. Alcoholism Clinicinal and Experimental Research 2019; 43(7): 1533-1544. doi:10.1111/acer.14067.

41. Scott C.K., Dennis M.L., Laudet A., Funk R.R., Simeone R.S. Surviving drug addiction: the effect of treatment and abstinence on mortality. Am J Public Health 2011; 101(4): 737-744. doi: 10.2105/AJPH.2010.197038.

42. Marmorstein N.R. Associations between subtypes of major depressive episodes and substance use disorders. Psychiatry Res. 2011; 186(2-3): 248-253. doi: 10.1016/j.psychres.2010.10.003.

43. Khosravani V., Sharifi Bastan F., Kolubinski D.C., Amirinezhad A., Ghorbani F. Distress tolerance and special alcohol metacognitions behave differently in the association of negative affect with alcohol-related patterns in men with problematic alcohol use in the abstinence phase. Clin Psychol Psychother. 2021; 28(2): 345-354. doi: 10.1002/cpp.2514.

44. Hasin D.S., Goodwin R.D., Stinson F.S., Grant B.F. Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions. Arch Gen Psychiatry 2005; 62: 1097-1106. doi: 10.1001/archpsyc.62.10.1097.

45. Davis L., Uezato A., Newell J.M., Frazier E. Major depression and comorbid substance use disorders. Curr Opin Psychiatry 2008; 21(1): 14-18. doi: 10.1097/YCO.0b013e3282f32408.

46. Ilyuk R.D., Il'jushkina E.V., Svjatenko V.S., Dzhalilova Z.O., Gromyko D.I., Erofeeva N.A., Berno-Bellekur I.V., Torban M.N., Kiselev A.S., Neznanov N.G., Krupitsky E.M. Sravnitel'noe issledovanie social'no-psihologicheskih, povedencheskih i klinicheskih harakteristik opioidzavisimyh s VICh-pozitivnym i VICh-negativnym statusami. Soobshhenie 2: Sravnitel'nyj analiz lichnostnyh harakteristik, pokazatelej agressii i gneva, koping-strategij, smyslozhiznennyh orientacij, stigmatizacii, kachestva zhizni. [Comparative study of socio-psychological, behavioral and clinical characteristics of opioid addicts with HIV-positive and HIV-negative statuses. Message 2: Comparative analysis of personality characteristics, indicators of aggression and anger, coping strategies, meaningful life orientations, stigmatization, quality of life]. Obozrenie psihiatrii i medicinskoj psihologii imeni V.M. Behtereva [Review of Psychiatry and Medical Psychology named by V.M. Bekhterev]. 2016; (4): 25-41. EDN XRIEMF. (In Russ.)

47. Pettinati H.M., O'Brien C.P., Dundon W.D. Current status of co-occurring mood and substance use disorders: a new therapeutic target. Am J Psychiatry 2013; 170(1): 23-30. doi: 10.1176/appi.ajp.2012.12010112.

48. Nunes E.V., Hennessy G., Slezer J. Depression in patients with substance use disorders, in Substance Dependence and Co-Occurring Psychiatric Disorders. Edited by Nunes E.V., Selzer J., Levounis P., Davies C.A.. Kingston, NJ, Civic Research Institute, 2010, pp 1.1–1.36.

49. Warden D., Sanchez K., Greer T., Carmody T., Walker R., Dela Cruz A., Toups M., Rethorst C., Trivedi M.H. Demographic and clinical characteristics of current comorbid psychiatric disorders in a randomized clinical trial for adults with stimulant use disorders. Psychiatry Res. 2016; 246: 136-141. doi: 10.1016/j.psychres.2016.09.007.

50. Cruise K.E., Becerra R. Alexithymia and problematic alcohol use: A critical update. Addictive Behaviors 2018; 77: 232-246. doi: 10.1016/j.addbeh.2017.09.025.

51. Thorberg F.A., Young R.M., Sullivan K.A., Lyvers M. Alexithymia and alcohol use disorders: A critical review. Addictive Behaviors 2009; 34(3): 237-245. doi: 10.1016/j.addbeh.2008.

52. Swan J.E., Votaw V.R., Stein E.R., Witkiewitz K. The role of affect in psychosocial treatments for substance use disorders. Current Addiction Reports 2020; 7: 108-116. doi: 10.1007/s40429-020-00304-0.

53. Rudenstine S., Espinosa A., Kumar A.J. Depression and anxiety subgroups across alcohol use disorder and substance use in a National Epidemiologic Study. Dual Diagn. 2020; 16(3): 299-311. doi: 10.1080/15504263.2020.1784498.

54. Rinehart L.M., Anker J., Unruh A., Degeneffe N., Thuras P., Norden A., Hartnett L., Kushner M. Supplemental Intervention for alcohol use disorder treatment patients with a co-occurring anxiety disorder: technical development and functional testing of an autonomous digital program. JMIR Form Res. 2024; 8:e62995. doi: 10.2196/62995.

55. Magidson J.F., Liu S.M., Lejuez C.W., Blanco C. Comparison of the course of substance use disorders among individuals with and without generalized anxiety disorder in a nationally representative sample. J Psychiatr Res. 2012; 46: 659-666. doi: 10.1016/j.jpsychires.2012.02.011.

56. Fuchshuber J., Andres D., Prandstätter T., Roithmeier L., Schmautz B., Schwerdtfeger A., Unterrainer H.F. Influence of anxious attachment on the relationship between primary emotions and substance-related addictive behaviors. Front Public Health 2024; 12: 1380539. doi: 10.3389/fpubh.2024.1380539.

57. Schuler M.S., Puttaiah S., Mojtabai R., Crum R.M. Perceived barriers to treatment for alcohol problems: a latent class analysis. Psychiatr Serv. 2015; 66(11): 1221-1228. doi: 10.1176/appi.ps.201400160.

58. Chou S.P., Lee H.K., Cho M.J., Park J.I., Dawson D.A., Grant B.F. Alcohol use disorders, nicotine dependence, and co-occurring mood and anxiety disorders in the United States and South Korea-a cross-national comparison. Alcohol Clin Exp Res. 2012; 36(4): 654-62. doi: 10.1111/j.1530-0277.2011.01639.x.

59. Le Berre A.P. Emotional processing and social cognition in alcohol use disorder. Neuropsychology 2019; 33(6): 808-821. doi: 10.1037/neu0000572.

60. Miloslavich K., Wardle M. Anger is more strongly associated with alcohol and tobacco use and use disorders compared to other substances in American adults. Am J Drug Alcohol Abuse 2024; 50(4): 433-441. doi: 10.1080/00952990.2024.2331721.

61. Batmaz M., Yazici H.G., Akhan L.U. Trait anger – Anger expression style and coping with stress in alcohol and substance use disorders: A randomized and controlled study. Arch Psychiatr Nurs. 2023; 43: 43-49. doi: 10.1016/j.apnu.2022.12.018.

62. Laitano H.V., Ely A., Sordi A.O., Schuch F.B., Pechansky F., Hartmann T., Hilgert J.B., Wendland E.M, Von Dimen L., Scherer J.N., Calixto A.M., Narvaez J.C.M., Ornell F., Kessler F.H.P. Anger and substance abuse: a systematic review and meta-analysis. BrazJPsychiatry 2022; 44 (1): 103-110. doi: 10.1590/1516-4446-2020-1133.

63. Serafini K., Toohey M.J., Kiluk B.D., Carroll K.M.J. Anger and its association with substance use treatment outcomes in a sample of adolescents. Child Adolesc Subst Abuse 2016; 25(5): 391-398. doi: 10.1080/1067828X.2015.1049394.

64. Ilyuk R.D., Gromyko D.I., Kiselev A.S., Torban M.N., Krupitsky E.M. Hostility and anger in patients dependent on different psychoactive drugs. Activitas Nervosa Superior 2012; 54 (3-4): 125-134. doi: 10.1007/BF03379590.

65. Brady T.M., Ashley O.S., editors. Women in substance abuse treatment: results from the alcohol and drug services study (adss) rockville, md: substance abuse and mental health services administration, office of applied studies; 2005. DHHS Publication No. SMA 04-3968, Analytic Series A-26. 104р.

66. Hellem T.L., Lundberg K.J., Renshaw P.F. A review of treatment options for co-occurring methamphetamine use disorders and depression. J Addict Nurs. 2015; 26(1): 14–E1. doi: 10.1097/JAN.0000000000000058

67. Eddie D., White W.L., Vilsaint C.L., Bergman B.G., Kelly J.F. Reasons to be cheerful: Personal, civic, and economic achievements after resolving an alcohol or drug problem in the United States population. Psychol Addict Behav. 2021; 35(4): 402-414. doi: 10.1037/adb0000689.

68. Gromyko D.I., Nechaeva A.I., Erofeeva N.A., Kiselev A.S., Krupickij E.M., Ilyuk R.D. Issledovanie roli social'no-demograficheskih, klinicheskih i psihojemocional'nyh harakteristik v formirovanii motivacii k izmeneniju i lecheniju u bol'nyh s sindromom zavisimosti ot opioidov. [Study of the role of socio-demographic, clinical and psycho-emotional characteristics in the formation of motivation for change and treatment in patients with opioid addiction syndrome]. Narkologija [Narcology] 2021; 20 (11): 12-23 (In Russ.)

69. Gromyko D.I., Nechaeva A.I., Erofeeva N.A., Alekseeva Ju.V., Kiselev A.S., Krupitsky E.M., Ilyuk R.D. Osobennosti social'no-demograficheskih, klinicheskih, psihojemocional'nyh pokazatelej i lichnostnyh harakteristik zavisimyh ot stimuljatorov s razlichnym urovnem motivacii k lecheniju. [Features of socio-demographic, clinical, psycho-emotional indicators and personal characteristics of people addicted to stimulants with different levels of motivation for treatment]. Narkologija [Narcology] 2022; 21 (10): 16-30. doi: 10.25557/1682-8313.2022.10.16-30. (In Russ.)

70. D’Amico E.J., Houck J.M., Hunter S.B., Miles J.N.V., Osilla K.C., Ewing B.A. Group motivational interviewing for adolescents: Change talk and alcohol and marijuana outcomes. Journal of Consulting and Clinical Psychology 2015; 83(1): 68-80. doi: 10.1037/a0038155.

71. Miller W.R., Moyers T.B. The forest and the trees: Relational and specific factors in addiction treatment. Addiction 2015; 110 (3): 401-413. doi: 10.1111/add.12693.

72. Best D., Beckwith M., Haslam C., Haslam S.A., Jetten J., Mawson E., Lubman D.I. Overcoming alcohol and other drug addiction as a process of social identity transition: the social identity model of recovery (SIMOR). Addict Res Theory 2016; 24: 111-123. doi:10.3109/16066359.2015.1075980.

73. Day E., Manitsa I., Farley A., Kelly J.F. A UK national study of prevalence and correlates of adopting or not adopting a recovery identity among individuals who have overcome a drug or alcohol problem. Subst Abuse Treat Prev Policy. 2023; 18(1): 68. doi: 10.1186/s13011-023-00579-2.

74. Ilyuk R.D., Gromyko D.I., Tarhan A.S., Pimenova L.V., Ovechkina I.V Nejrokognitivnye rasstrojstva u bol'nyh s opiatnoj zavisimost'ju i ih nejropsihologicheskaja diagnostika: posobie dlja vrachej [Neurocognitive disorders in patients with opiate addiction and their neuropsychological diagnosis: a manual for physicians]. Sankt-Peterburg: federal'noe gosudarstvennoe bjudzhetnoe uchrezhdenie «Nacional'nyj medicinskij issledovatel'skij centr psihiatrii i nevrologii imeni V.M. Behtereva» Ministerstva zdravoohranenija Rossijskoj Federacii, 2008. 48 p. ISBN 978-5-94651-035-6. EDN JaLTESB. (In Russ.)

75. Ilyuk R.D., Gromyko D.I., Berno-Bellekur I.V. Issledovanie vlijanija kliniko-psihologicheskih faktorov na motivaciju k otkazu ot potreblenija psihoaktivnyh veshhestv. [Study of the influence of clinical and psychological factors on the motivation to refuse the use of psychoactive substances]. Psihicheskoe zdorov'e [Mental health] 2010; 7 (50): 36-42. (In Russ.)